Dear ICRM Community, As the situation has continued to evolve with the novel coronavirus COVID-19, so have the recommendations of experts around the world including both CDC and WHO.
Earlier today our governing body, ASRM (American Society of Reproductive Medicine), issued guidelines to clinics for patient care until at least March 30, 2020. This includes:
- Stopping initiation of new treatments cycles for ovulation induction, IUI, IVF, and frozen embryo transfers
- Suspending elective surgeries and non-urgent diagnostic procedures (semen analysis, hysterosalpingogram saline sonogram (water ultrasound), ERA biopsy
-Minimizing in-person interactions
“These recommendations are aimed at guarding the health and safety of patients and providers while recognizing it’s our social responsibility and as an organization and as a community of providers and experts to comply with national public health recommendations and apply them to all reproductive settings during this unprecedented time.” –ASRM Bulletin
As we all know, the situation is ever-evolving and we are taking all steps necessary to comply with national public health recommendations to safeguard our community as a whole. The conversation will continue to evolve in the coming days and the physicians will revisit the topic as ASRM offers more guidance (next expected update 03/30/2020).
We absolutely understand this is difficult to hear. Please know that our aim is to resume usual patient care as soon and as safely possible. We will post updates as they are available.